- Physician reports show signals of efficacy and safety consistent with previously disclosed data, as well as maintenance of clinical effect beyond 12 weeks and high retention rate - - Data to be presented at R&D Day today commencing at 10:00 a.m. ET, 15:00 BST -
12 patients with Dravet syndrome reported a median overall reduction in convulsive seizure frequency of 51%-72% across a range of time points and analyses
12 patients with drop seizures (the types of seizures considered by the FDA in assessing primary efficacy for Lennox-Gastaut Syndrome trials) at baseline reported a median overall reduction in drop seizure frequency of 52%-76%
Data on 58 patients with a wide range of drug-resistant epilepsies treated with Epidiolex show a median overall reduction in total seizure frequency of 36%-51%
Overall, 40-70% of patients obtained a greater than 50% reduction in seizure frequency with a notable proportion achieving
By Trey Williams, MarketWatch
Amazon to debut "Bosch", based on books by Michael Connelly
NEW YORK (MarketWatch)--Amazon.com Inc. fresh from its Golden Globe success on Sunday, has set a release date for the initial season of "Bosch," its first hour-long original drama.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.